Partners & ecosystem
We work with clinical, academic, and innovation partners to advance rigorous validation and equitable access.
VascuSense combines patch-based capillary blood collection, microfluidic proteomics, and data-driven interpretation to support decentralized screening for mild cognitive impairment and Alzheimer’s disease—making biomarker-based assessment more accessible before symptoms advance.
Point-of-care and at-home diagnostics for cognitive health—developed with support from Canada’s aging and brain health ecosystem.
Patch collection, laboratory-grade proteomic analysis from tiny samples, and screening-oriented interpretation—designed for real-world, decentralized use.
A minimally invasive, patch-based capillary workflow collects small-volume blood samples without a conventional venous draw—reducing burden for older adults and enabling use outside the clinic.
Low-volume plasma preparation and multiplex proteomic analysis are tuned for biomarkers relevant to MCI and Alzheimer’s disease—including tau-, amyloid-, and neurodegeneration-associated proteins.
Machine learning and statistical methods evaluate biomarker patterns to support screening-oriented readouts and a pathway toward broader brain-health applications over time.
We work with clinical, academic, and innovation partners to advance rigorous validation and equitable access.
We are advancing participant-based studies to evaluate usability, sample quality, and biomarker performance—connect with us for research collaborations or trial recruitment discussions.
Contact VascuSense